Rheumatoid Arthritis Clinical Trials in San Antonio

Showing 621-640 of 2,360 trials

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment

NCT06274788

This study will demonstrate safety in pediatric patients with Parenteral Nutrition-Associated Cholestasis treated with Omegaven®, which is indicated as a source of calories and fatty acids in this patient population

Parenteral Nutrition Associated Liver Disease (PNALD)Essential Fatty Acid DeficiencyMalnutrition+1 more

Fresenius Kabi40 participantsStarted Dec 2024

Fountain Valley, California, United States • Los Angeles, California, United States • Chicago, Illinois, United States +7 more locations

TERMINATEDPhase 2< 1 mile

A Study of Danicopan in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

NCT05019521

This is a dose finding study designed to evaluate the efficacy, safety, and pharmacokinetics of danicopan in participants with GA secondary to AMD. The study consists of a Screening Period of up to 6 weeks, a 104-week masked Treatment Period, followed by a 30-day Follow-up after the last dose. This study will have 4 treatments arms: 100 milligrams (mg) twice daily (bid), 200 mg bid, 400 mg once daily (qd), and matching placebo.

Geographic Atrophy

Alexion Pharmaceuticals, Inc.365 participantsStarted Aug 2021

Phoenix, Arizona, United States • Beverly Hills, California, United States • Encino, California, United States +125 more locations

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment

A Study of Danicopan in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Rheumatoid Arthritis Trials in Other Cities

Combining Stellate Ganglion Block With Prolonged Exposure for PTSD

Safety and Tolerability Study of Daily Dosing Rimegepant in Episodic Migraine Prevention

Telehealth 2.0: Evaluating Effectiveness and Engagement Strategies for CPT-Text for PTSD

Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)

Study of INV-102 Ophthalmic Solution in Adults With Acute Infectious Keratoconjunctivitis

A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Elismetrep (K-304) in the Treatment of Migraine

A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome

Study of JK07 in Patients With Chronic Heart Failure

Expanded Access Program for Revumenib

A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors

Impact of a Health Technology Intervention on Patient Activation in Multiple Myeloma

Treatment of GVHD in Hematopoietic Stem Cell Transplant (HSCT) Recipients Using AAT Plus Corticosteroids (CS) Compared With Corticosteroids Alone

Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer

The Care Ecosystem Consortium Effectiveness Study

Mitral Valve Screening Survey

Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T

Effect of Evolocumab on Saphenous Vein Graft Patency Following Coronary Artery Bypass Surgery

An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant

Other Conditions in San Antonio